We are investigating the safety and early signs of effectiveness of the IL12-L19L19 treatment. This study is for individuals who may benefit from new therapeutic options.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced carcinoma refers to cancer that has spread from its original site to other parts of the body, often requiring more aggressive treatment options. This condition may occur after previous treatments, such as immune checkpoint blockade therapy.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
